Lacia, Baby Boy S.
HRN: 21-74-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/13/2022
08/19/2022
IVTT
97mg
Od X 7 Days
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes